在患有浮游植物的患者中评估异原体指数:一个病例对照研究
Burak Celik1, Merve Kaya2, Gulhan A Saraç2
1Internal Medicine, Cook County Health, Chicago, USA.
Cureus
|June 26, 2025
概括
患有李氏平斑 (LPP) 的患者表现出血脂水平升高和动脉动脉指数升高,表明心血管风险增加. 这凸显了需要警的脂质和心血管监测在LPP患者.
科学领域:
- 皮肤病学 皮肤病学
- 心脏病学 心脏病学
- 生物化学 生物化学
背景情况:
- 斑 (LPP) 是一种痕性脱发症,导致永久性脱发.
- 慢性甲状腺炎与甲状腺功能低下和心血管疾病等系统性疾病有关.
- 了解LPP与心血管风险因素的关联至关重要.
研究的目的:
- 评估LPP患者的血清脂质参数.
- 评估LPP中心血管风险的有机体指数.
- 为了比较LPP患者和健康对照人群之间的脂质资料.
主要方法:
- 对115名LPP患者和115名对照患者的回顾性分析.
- 收集了血清总胆固醇,甘油三 (TG),高密度胆固醇和低密度胆固醇的数据.
- 计算的等离子体无氧化物指数 (AIP),卡斯特利风险指数 (CRI) I和II,以及无氧化物系数 (AC).
主要成果:
- 在LPP患者中,TG,总胆固醇,LDL和非HDL胆固醇显著增加.
- 在LPP患者中观察到升高的CRI-I,CRI-II和AC.
- 在CRI-I,CRI-II和AC方面,LPP患者更频繁地被分为高风险组.
结论:
- 患有LPP的患者具有亲atherogenic脂质特征和升高的atherogenic指数.
- 系统性炎症和PPAR信号可能会导致这种关联.
- 建议对LPP患者进行加强的心血管和脂质监测.
相关概念视频
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Atherosclerosis I: Introduction
93
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
93
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
42
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
42


